logo
  • genedrive.com
  • About us
    • Company profile
    • Board of directors
    • Advisors
  • Our product
  • News & Events
    • Press releases
    • Events
    • Media
  • Careers
    • Careers
    • Applicants Privacy Notice
  • Investor relations
    • Investor relations
    • Shareholders
    • Share price information
    • Regulatory news
    • Reports & presentations
    • Constitutional documents
    • Investor news
    • Corporate governance
    • AIM Rule 26

Media

Home > News & Events > Media
  • Press releases
  • Events
  • Media

Wednesday May 02, 2018

Genedrive validates near-patient HCV assay

NEW YORK (GenomeWeb) – Genedrive plc, a Manchester, UK-based company formerly known as Epistem, has completed validation studies of its point-of-care molecular diagnostics system and assay for hepatitis C virus. The studies were conducted in Europe as well as South Africa to demonstrate the assay works on genotypes predominate in different global regions.

Download PDF

share
  • Privacy
  • Terms of use
  • Site map
  • Contact us

© 2017-18 genedrive plc

genedrive plcThis site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this againclose